BRD4 and acute myeloid leukemia: We found that inhibition of BRD4 with chemical inhibitors markedly reduced PD-1 and Tim-3 expression on Jurkat T cells, primary T cells, HA-28z CAR T cells, and T cells from patients with AML, and siBRD4 could suppress PD-1 expression on Jurkat T cells.